Physician

David Christianson, M.D.

According to 2025 Medicare claims, David Christianson, M.D. (NPI: 1770565871) practices hematology/oncology in the Billings, MT market, with the plurality of this provider's patient population coming from Yellowstone, MT. This provider's primary affiliated billing organization is SCL HEALTH MONTANA (NPI: 1225389265; TIN: 81-0232124) and primary practice location at 59102-6746. Christianson is affiliated with the Rocky Mountain Accountable Health Network, Inc (ACO ID: A2217), Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Christianson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 475 traditional Medicare patients, billed 2,870 HCPCS/CPT codes, and received $147,094 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,939 prescription claims across 347 beneficiaries totaling $6,523,813 in drug costs, led by Xtandi (Enzalutamide). DME data shows 12 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $90,235 to $147,094. Similarly, Part D prescription costs have moved sharply higher in recent years, from $701,697 to $6,523,813. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,587 and ending at $1,113.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	310	1,557	$90,235
2016	346	1,424	$81,747
2017	416	1,549	$89,988
2018	486	1,700	$97,343
2019	431	1,541	$98,206
2020	406	1,526	$95,458
2021	531	2,228	$178,111
2022	551	2,370	$171,417
2023	521	2,086	$146,106
2024	475	2,870	$147,094

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	184	1,524	$701,697
2016	160	1,558	$403,191
2017	185	1,568	$461,955
2018	198	1,545	$1,033,372
2019	230	1,886	$2,007,457
2020	232	1,909	$2,979,826
2021	295	2,508	$3,674,681
2022	339	2,858	$4,777,116
2023	352	2,977	$6,900,959
2024	347	2,939	$6,523,813

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	14	$1,598
2017	N/R	11	$727
2018	N/R	26	$901
2019	N/R	N/R	N/R
2020	N/R	50	$2,133
2021	N/R	70	$3,048
2022	N/R	70	$1,968
2023	N/R	24	$1,682
2024	N/R	12	$857

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	93	145	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	323	1,179	$69
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	253	618	$48
99441	Telephone medical discussion with physician, 5-10 minutes	60	135	$25
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	326	710	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	72	2,160	$807,961
Brukinsa	Zanubrutinib	41	1,230	$551,344
Jakafi	Ruxolitinib Phosphate	31	930	$474,260
Lenvima	Lenvatinib Mesylate	24	706	$444,007
Ayvakit	Avapritinib	11	328	$405,067

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$857

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for David Christianson, M.D.?

Tedicare shows public-source Medicare data for David Christianson, M.D. (NPI 1770565871), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Christianson, M.D. have ACO affiliation data?

David Christianson, M.D. is shown with ACO affiliation data for Rocky Mountain Accountable Health Network, Inc (MSSP, ACO ID A2217), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to David Christianson, M.D.?

David Christianson, M.D. is linked to SCL HEALTH MONTANA (billing NPI 1225389265) in the available physician profile data.

Does David Christianson, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.